Thompson Peter A.'s Form 4 filing
Edgewise Therapeutics, Inc. (EWTX) · filed Apr 4, 2025
- Accession no.
- 0000947871-25-000360
- Filed
- Apr 4, 2025
- Trade date
- Apr 3, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $10.0M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thompson Peter A.CIK 0001357522 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | Common Stock | PPurchaseAcquired | +372,578 | $20.13 | +$7,499,995.14 | 14,809,075 | Indirect | |
| Apr 3, 2025 | Common Stock | PPurchaseAcquired | +124,193 | $20.13 | +$2,500,005.09 | 443,792 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.